Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

MKSAP: 21-year-old woman with type 1 diabetes

mksap
Conditions
November 26, 2016
Share
Tweet
Share

A 21-year-old woman is evaluated for management of type 1 diabetes. She was diagnosed 3 months ago after presenting to the emergency department with diabetic ketoacidosis. Her HbA1c level at the time of diagnosis was 15.2%. She was discharged from the hospital on a basal and prandial insulin regimen with minor adjustments required as an outpatient. Her blood glucose log demonstrates a recent change manifesting as frequent symptomatic episodes of both fasting and postprandial hypoglycemia with blood glucose levels ranging from 50 to 65 mg/dL (2.8 to 3.6 mmol/L). Medications are insulin glargine and insulin aspart.

On physical examination, blood pressure is 110/70 mm Hg and pulse rate is 70/min. BMI is 19. The remainder of the examination is unremarkable. HbA1c level is 6.2%.

Which of the following is the most appropriate management for this patient’s hypoglycemia?

A. Decrease insulin glargine, decrease insulin aspart
B. Decrease insulin glargine, decrease insulin aspart, add pramlintide
C. Discontinue insulin glargine, change insulin aspart to a sliding-scale regimen
D. Discontinue insulin glargine, discontinue insulin aspart

MKSAP Answer and Critique

The correct answer is A. Decrease insulin glargine, decrease insulin aspart.

The most appropriate management for this patient’s hypoglycemia is to decrease insulin glargine and insulin aspart. The glucose toxicity present at the time of diabetic ketoacidosis has diminished with an intensive insulin regimen. Her remaining functional pancreatic beta cells have regained the ability to produce some insulin in the “honeymoon” phase, which explains the hypoglycemia on previously well-tolerated doses of insulin. The decreased need for insulin will not be long term as pancreatic beta cells continue to be destroyed over the course of type 1 diabetes. Continuing insulin, even at low doses, is recommended during the “honeymoon” phase in order to preserve beta cell function as long as possible by reducing the metabolic stress on these cells. The low-dose insulin regimen can consist of a basal and prandial insulin combination or a basal insulin regimen. She is experiencing symptomatic postprandial and fasting hypoglycemia. Decreasing the insulin aspart and insulin glargine doses would address the prandial and fasting hypoglycemia, while also still providing low-dose insulin to protect the functioning beta cells. She will require close monitoring of her blood glucose levels to determine when insulin doses should be increased as she nears the end of the “honeymoon” phase. The “honeymoon” period may persist for several weeks to months.

Meal-time insulin doses are generally reduced by 50% when pramlintide is initiated due to the risk of hypoglycemia. The addition of pramlintide would likely exacerbate the current issue of hypoglycemia even with reduction of meal-time insulin.

The use of sliding-scale insulin without basal insulin is discouraged. When sliding-scale insulin is used without basal insulin, the likelihood of wide swings from hyperglycemia to hypoglycemia increases. Without a basal insulin regimen, she may not consistently receive daily insulin to decrease the metabolic stress on her functioning pancreatic beta cells.

Discontinuation of both insulin glargine and insulin aspart increases metabolic stress on the pancreatic beta cells and accelerates the loss of functional cells producing insulin. As pancreatic beta cell function declines toward the end of the “honeymoon” phase, the risk of diabetic ketoacidosis increases without any exogenous insulin.

Key Point

  • Continuing insulin, even at low doses, is recommended during the “honeymoon phase” of type 1 diabetes mellitus to reduce metabolic stress on functioning beta cells and preserve any residual function for as long as possible.

This content is excerpted from MKSAP 17 with permission from the American College of Physicians (ACP). Use is restricted in the same manner as that defined in the MKSAP 16 Digital license agreement. This material should never be used as a substitute for clinical judgment and does not represent an official position of ACP. All content is licensed to KevinMD.com on an “AS IS” basis without any warranty of any nature. The publisher, ACP, shall not be liable for any damage or loss of any kind arising out of or resulting from use of content, regardless of whether such liability is based in tort, contract or otherwise.

Prev

Doctors should take care of teddy bears too

November 25, 2016 Kevin 0
…
Next

Is independent practice better for doctors or patients?

November 26, 2016 Kevin 22
…

Tagged as: Diabetes

Post navigation

< Previous Post
Doctors should take care of teddy bears too
Next Post >
Is independent practice better for doctors or patients?

ADVERTISEMENT

More by mksap

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 26-year-old man with back pain

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 36-year-old man with abdominal cramping, diarrhea, malaise, and nausea

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 52-year-old woman with osteoarthritis of the right hip

    mksap

Related Posts

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 45-year-old woman with type 2 diabetes mellitus

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 35-year-old woman with constipation

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 60-year-old woman with persistent constipation

    mksap
  • Type 1 diabetes is no fun

    Ryan Ritchie
  • Why you shouldn’t be happy with $137 insulin

    Elisabeth Rosenthal, MD
  • 3 ways we’ve failed woman who breastfeed

    Joanna Buscemi, PhD

More in Conditions

  • How President Biden’s cognitive health shapes political and legal trust

    Muhamad Aly Rifai, MD
  • The emotional first responders of aesthetic medicine

    Sarah White, APRN
  • Why testosterone matters more than you think in women’s health

    Andrea Caamano, MD
  • How veteran health care is being transformed by tech and teamwork

    Deborah Lafer Scher
  • What Elon Musk and Diddy reveal about the price of power

    Osmund Agbo, MD
  • Understanding depression beyond biology: the power of therapy and meaning

    Maire Daugharty, MD
  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...